Geriatrics News and Research

RSS

New study investigates PFAS exposure and future inflammatory bowel disease

Exposure to per- and polyfluoroalkyl substances (PFAS), often called "forever chemicals," may play a role in the development of inflammatory bowel disease (IBD) years before symptoms appear, according to a new five-year study supported by a $3.3 million National Institutes of Health (NIH) R01 grant to researchers at the Icahn School of Medicine at Mount Sinai.

5 Oct 2026

Swedish study links lower midlife cognitive scores to future strokes

Adults in their 60s who scored lower on tests of overall thinking ability, memory and how quickly they processed information were more likely to have a stroke years later, according to new research conducted in Sweden, published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

30 Sep 2026

Mount Sinai researchers discover how Alzheimer's gene damages blood vessels

Mount Sinai researchers have identified how APOE4, the strongest genetic risk factor for Alzheimer's disease, damages the brain's blood vessels and promotes the buildup of abnormal proteins linked to neurodegenerative disease.

24 Sep 2026

Older adults with higher polyphenol intake were less likely to have mild cognitive impairment

In a cross-sectional study of 92 older Italian memory-clinic patients, higher habitual intake of total dietary (poly)phenols and several specific subclasses was associated with a lower likelihood of mild cognitive impairment (MCI). Total (poly)phenol intake was not associated with cognitive test performance or circulating inflammatory biomarkers, and the authors cautioned that the small observational study cannot establish causality.

20 Sep 2026

Social media posts misrepresent Alzheimer's blood test recommendations

Researchers have raised concerns about the promotion of Alzheimer's disease blood tests on social media, particularly posts making claims that do not align with current clinical recommendations.

17 Sep 2026

Study highlights drop in harmful medication use among adults with cognitive disorders

Adults 65 and older with cognitive disorders such as dementia, are more likely to suffer negative effects from drugs that treat central nervous system conditions including anxiety, sleep problems and psychosis.

17 Sep 2026

Wildfire smoke poses greater health risks than other pollution

As climate change drives more frequent and intense wildfires, researchers at the Icahn School of Medicine at Mount Sinai have published two large-scale studies showing that wildfire smoke may pose greater health risks than other sources of air pollution, with higher risks of hospitalization for cardiovascular and respiratory disease and poorer survival among patients with lung cancer.

17 Sep 2026

Neighborhood environments impact long-term health of 9/11 responders

Twenty-five years after the September 11 terrorist attacks, researchers at the Icahn School of Medicine at Mount Sinai have found that environmental conditions where World Trade Center responders live may influence their long-term physical and mental health.

11 Sep 2026

Groundbreaking movement span framework redefines how we measure aging

Longstanding aging metrics have focused on how long people live and how long they live free of chronic disease, but both overlook a core component of daily well-being: the ability to move through the world with ease and confidence.

10 Sep 2026

Community brain health programs successfully improve attention in older adults

As aging populations drive rising global healthcare demands, finding scalable ways to prevent cognitive decline has become a vital public health priority.

4 Sep 2026

NIH grant funds research on environmental triggers for sickle cell disease

The Icahn School of Medicine at Mount Sinai has received a $4.1 million grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to study how everyday exposures affect the health of people with sickle cell disease.

1 Sep 2026

Parkinson’s disease imposes €22.8 billion economic burden across Europe

The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019, equivalent to €28.8 billion at 2025 prices, a new study published today in Movement Disorders has shown.

27 Aug 2026

Real-world study shows Oregon psilocybin services relieve mental health symptoms

People participating in an Oregon Health & Science University-led study of state-regulated psilocybin services reported relief from symptoms of anxiety, depression and post-traumatic stress disorder - with almost two-thirds declaring the experience to be among the most meaningful of their life.

19 Aug 2026

Study analyzes how BMI and waist circumference affect mortality in older adults

In a Journal of the American Geriatrics Society analysis of nationally representative data from 6,905 US adults aged 65 or older followed between 2011–2024, higher body mass index (BMI) was associated with lower mortality risk, whereas higher waist circumference, a marker of abdominal obesity, was independently associated with higher mortality risk after accounting for BMI.

19 Aug 2026

Youth-associated protein reverses age-related microglial changes in mice

Researchers at The Icahn School of Medicine at Mount Sinai have identified a role for the youth-associated protein TIMP2 in supporting the healthy function of microglia, the brain's resident immune cells.

14 Aug 2026

Preoperative combination therapy improves head and neck cancer outcomes

Patients with head and neck cancer who received chemotherapy in addition to immunotherapy before surgery had a significantly reduced tumor size at the time of operation than patients who received immunotherapy alone.

13 Aug 2026

UC San Diego and West Health launch new national healthcare model

America's health care system is under pressure with demand rising, hospital capacity strained and the number of patients who need care the most increasing faster than the system was built to serve.

12 Aug 2026

AI tool aims to accelerate Alzheimer's treatment through faster referrals

Vanderbilt Health researchers have received a grant from Eli Lilly and Company, a multinational pharmaceutical company headquartered in Indianapolis, to build an artificial intelligence (AI) tool within the electronic health record system (EHR) to get patients with Alzheimer's disease to treatment faster.

5 Aug 2026

Latest hospital rankings place NYU Langone Health at the very top

NYU Langone Health continues to have the most No. 1-ranked specialties and the most top-10 ranked specialties among medical centers in the United States, according to the rankings released today by U.S. News & World Report.

4 Aug 2026

Tailored online nutrition tools empower frail older adults

While existing digital health tools can provide valuable information to offset poor nutrition, older adults with pre-frailty and frailty want to engage with these tools easily, to support their autonomy, dietary self-management and healthy aging.

31 Jul 2026